NCT03837015View on ClinicalTrials.gov

Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 4, 2019

Primary Completion Date

December 14, 2021

Study Completion Date

December 14, 2021

Conditions
HIV-1-infectionBacterial Vaginoses
Interventions
DRUG

Estring Vaginal Ring

Estradiol vaginal ring, containing 2mg estradiol designed for slow release over 30 days

OTHER

RepHresh Pro-B

Probiotic supplement containing 2.5 billion CFU of Lactobacilli reuteri RC-14 and Lactobacilli rhamnosus GR-1, administered vaginally or orally

Trial Locations (1)

M5B1J3

Women's Health in Women's Hands, Toronto

All Listed Sponsors
collaborator

CIHR Canadian HIV Trials Network

NETWORK

lead

McMaster University

OTHER

NCT03837015 - Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women | Biotech Hunter | Biotech Hunter